ISM-4808

N/A

Report date: 2026/04/11 20:00:19
NME

Base Information

Drug NameISM-4808
Drug Alias NameISM4808ISM-4808
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl hydroxylase domain-containing protein 1 inhibitorsProlyl hydroxylase domain-containing protein 2 inhibitors
TargetsProlyl hydroxylase domain-containing protein 1Prolyl hydroxylase domain-containing protein 2
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdTaiGen Biotechnology Co LtdTaigen Pharmaceutical R & D (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A